
---
title: '鲁抗医药：注射用头孢曲松钠通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4703'
author: 证券时报网
comments: false
date: Wed, 13 Apr 2022 20:28:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4703'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600789" style="color: #2f67d1;text-decoration: none;" code="600789" target="_blank">鲁抗医药</a>(600789)4月13日晚间公告，注射用头孢曲松钠通过仿制药一致性评价。注射用头孢曲松钠适用于对本品敏感的致病菌引起的感染。</p>

                  
</div>
            